Cellbank's Partner Medical Institution, Oracle Beauty Clinic Tokyo Shinjuku, Exceeds 200 Cumulative Skin Regenerative Medicine Treatments
Cellbank's affiliated medical institution, Oracle Beauty Clinic Tokyo Shinjuku, has surpassed 200 cumulative skin regenerative medicine treatments using autologous cultured dermal fibroblasts. This achievement highlights Cellbank's robust cell processing and quality control system, along with strong collaboration with its partner clinics in the field of aesthetic regenerative medicine.
📋 Article Processing Timeline
- 📰 Published: May 1, 2026 at 19:00
- 🔍 Collected: May 1, 2026 at 10:31
- 🤖 AI Analyzed: May 1, 2026 at 23:17 (12h 45m after Collected)
Cellbank Co., Ltd. (Headquarters: Chuo-ku, Tokyo; Representative Director: Motoharu Hojo; hereinafter "the Company"), which operates a specified cell processed product manufacturing business, announces that its affiliated medical institution, Oracle Beauty Clinic Tokyo Shinjuku (Headquarters: Shinjuku-ku, Tokyo; Director: Masako Furuichi), has exceeded 200 cumulative treatments for skin regenerative therapy (hereinafter "skin regenerative medicine") using autologous cultured dermal fibroblasts provided by the Company. This milestone demonstrates the accumulation of significant treatment results in aesthetic medicine utilizing regenerative medicine, supported by the Company's cell processing and quality control system and its collaboration with affiliated medical institutions.
With expertise cultivated at the forefront of aesthetic medicine, including in Korea, Oracle Beauty Clinic Tokyo Shinjuku offers regenerative medicine not as "temporary beauty" but as a medical treatment that enhances long-term skin value.
The clinic conducts regular data measurements using a skin diagnostic device (VISIA) and creates comparative photographs, establishing an environment for examinations based on objective numerical values and images, even for areas where visual changes, such as fine wrinkles, are difficult to grasp. The clinic's patient base includes not only female patients but also a certain number of male patients, approached with consideration for differences in skin structure.
Furthermore, the clinic measures repeat rates as an objective indicator of treatment satisfaction; approximately 44% of patients choose additional treatments within 1-2 years after completing a two-session, one-set treatment for the same area. Cases have also been confirmed where patients gradually expand treatment areas from the face to the neck, back of the hands, and fingers, leading to continuous use. Precise examinations based on data are a supporting factor in reaching 200 cumulative treatments.
Building on the operational system developed at Oracle Beauty Clinic Tokyo Shinjuku, a consultation system for the same treatment by Dr. Furuichi has also been established at Tokyo Advanced Medical Clinic (Tokyo Aesthetic Surgery Akasaka Clinic, Headquarters: Minato-ku, Tokyo), a group affiliate. At this clinic, specialists handle consultations for treatments including osteotomy and regenerative medicine. By fostering medical collaboration based on specialized knowledge, they aim to share achievements in skin regenerative medicine and provide stable services.
■ About Cellbank
The Company was founded in 2004, before the term "regenerative medicine" was widely recognized. Following the enforcement of the "Act on the Safety of Regenerative Medicine, etc." in 2014, the Company obtained a license for specified cell processed product manufacturing from the Ministry of Health, Labour and Welfare in 2015. It possesses a cell culture and processing facility (CPC) with a floor area of approximately 300㎡, where it manufactures and stores cell processed products. The Company contracts with over 100 medical institutions nationwide, providing skin regenerative medicine (aesthetic field) and knee regenerative medicine (orthopedic field), performing over 5,000 culture procedures annually (as of January 2026). Leveraging its technical capabilities, including a track record of supporting introductions to medical institutions nationwide and over 20 years of cell storage experience, the Company comprehensively supports its affiliated medical institutions, including operational aspects.
■ Skin Regenerative Therapy as Medical Treatment, Using One's Own Cells
— Skin Regenerative Medicine —
Regenerative medicine aims to restore lost bodily functions and tissues using cells. Within this, skin regenerative medicine is an aesthetic therapy that cultivates a person's own dermal fibroblasts and transplants them into areas of the skin where cells have decreased. Dermal fibroblasts have the function of producing collagen, hyaluronic acid, and elastin, which maintain skin firmness and moisture. By transplanting and increasing dermal fibroblasts that have decreased due to aging, symptoms such as wrinkles and sagging are improved. Furthermore, since it is a treatment that replenishes one's own cells to "restore the original cellular state," its natural effect is a characteristic. By linking with a "cell storage" service, where dermal fibroblasts are cryopreserved and thawed for use at the desired time of transplantation, "current" dermal fibroblasts can be stored for the future and transplanted periodically. Through its cell storage service, the Company positions regenerative medicine not as an aesthetic procedure but as a long-term medical approach. Moving forward, the Company will continue to support the establishment of highly sustainable operational systems in collaboration with affiliated medical institutions.
■ Medical Corporation Tobikai Oracle Beauty Clinic Tokyo Shinjuku
〒160-0021
MLJ Shinjuku 6･8F, 3-19-4 Shinjuku, Shinjuku-ku, Tokyo
Director: Masako Furuichi
URL: https://www.oracleclinic.jp/
Medical Services: Dermatology, Aesthetic Dermatology, Aesthetic Surgery
■ Cellbank Co., Ltd.
〒104-0054
Inui Building Kachidoki 3･4F, 1-13-1 Kachidoki, Chuo-ku, Tokyo
Representative: Motoharu Hojo, Representative Director
URL: https://cellbank.co.jp/
Business Activities: Specified cell processed product manufacturing, Cell storage business, Regenerative medicine support business
■ Inquiries regarding this matter
Cellbank Co., Ltd.
Department in charge: Corporate Planning Department
With expertise cultivated at the forefront of aesthetic medicine, including in Korea, Oracle Beauty Clinic Tokyo Shinjuku offers regenerative medicine not as "temporary beauty" but as a medical treatment that enhances long-term skin value.
The clinic conducts regular data measurements using a skin diagnostic device (VISIA) and creates comparative photographs, establishing an environment for examinations based on objective numerical values and images, even for areas where visual changes, such as fine wrinkles, are difficult to grasp. The clinic's patient base includes not only female patients but also a certain number of male patients, approached with consideration for differences in skin structure.
Furthermore, the clinic measures repeat rates as an objective indicator of treatment satisfaction; approximately 44% of patients choose additional treatments within 1-2 years after completing a two-session, one-set treatment for the same area. Cases have also been confirmed where patients gradually expand treatment areas from the face to the neck, back of the hands, and fingers, leading to continuous use. Precise examinations based on data are a supporting factor in reaching 200 cumulative treatments.
Building on the operational system developed at Oracle Beauty Clinic Tokyo Shinjuku, a consultation system for the same treatment by Dr. Furuichi has also been established at Tokyo Advanced Medical Clinic (Tokyo Aesthetic Surgery Akasaka Clinic, Headquarters: Minato-ku, Tokyo), a group affiliate. At this clinic, specialists handle consultations for treatments including osteotomy and regenerative medicine. By fostering medical collaboration based on specialized knowledge, they aim to share achievements in skin regenerative medicine and provide stable services.
■ About Cellbank
The Company was founded in 2004, before the term "regenerative medicine" was widely recognized. Following the enforcement of the "Act on the Safety of Regenerative Medicine, etc." in 2014, the Company obtained a license for specified cell processed product manufacturing from the Ministry of Health, Labour and Welfare in 2015. It possesses a cell culture and processing facility (CPC) with a floor area of approximately 300㎡, where it manufactures and stores cell processed products. The Company contracts with over 100 medical institutions nationwide, providing skin regenerative medicine (aesthetic field) and knee regenerative medicine (orthopedic field), performing over 5,000 culture procedures annually (as of January 2026). Leveraging its technical capabilities, including a track record of supporting introductions to medical institutions nationwide and over 20 years of cell storage experience, the Company comprehensively supports its affiliated medical institutions, including operational aspects.
■ Skin Regenerative Therapy as Medical Treatment, Using One's Own Cells
— Skin Regenerative Medicine —
Regenerative medicine aims to restore lost bodily functions and tissues using cells. Within this, skin regenerative medicine is an aesthetic therapy that cultivates a person's own dermal fibroblasts and transplants them into areas of the skin where cells have decreased. Dermal fibroblasts have the function of producing collagen, hyaluronic acid, and elastin, which maintain skin firmness and moisture. By transplanting and increasing dermal fibroblasts that have decreased due to aging, symptoms such as wrinkles and sagging are improved. Furthermore, since it is a treatment that replenishes one's own cells to "restore the original cellular state," its natural effect is a characteristic. By linking with a "cell storage" service, where dermal fibroblasts are cryopreserved and thawed for use at the desired time of transplantation, "current" dermal fibroblasts can be stored for the future and transplanted periodically. Through its cell storage service, the Company positions regenerative medicine not as an aesthetic procedure but as a long-term medical approach. Moving forward, the Company will continue to support the establishment of highly sustainable operational systems in collaboration with affiliated medical institutions.
■ Medical Corporation Tobikai Oracle Beauty Clinic Tokyo Shinjuku
〒160-0021
MLJ Shinjuku 6･8F, 3-19-4 Shinjuku, Shinjuku-ku, Tokyo
Director: Masako Furuichi
URL: https://www.oracleclinic.jp/
Medical Services: Dermatology, Aesthetic Dermatology, Aesthetic Surgery
■ Cellbank Co., Ltd.
〒104-0054
Inui Building Kachidoki 3･4F, 1-13-1 Kachidoki, Chuo-ku, Tokyo
Representative: Motoharu Hojo, Representative Director
URL: https://cellbank.co.jp/
Business Activities: Specified cell processed product manufacturing, Cell storage business, Regenerative medicine support business
■ Inquiries regarding this matter
Cellbank Co., Ltd.
Department in charge: Corporate Planning Department